Waxman/Hatch Reform Bill Needed Despite FDA’s Rule – McCain, Schumer
Executive Summary
Legislation to reform the generic drug approval process will still be needed following issuance of FDA's final rule, Sens. John McCain (R-Ariz.) and Charles Schumer (D-N.Y.) said
You may also be interested in...
Medicare Law Puts Rx In Spotlight Of Presidential Campaign Politics
Restrictions on direct-to-consumer advertising of prescription drugs are among health care proposals being offered by 2004 Democratic presidential candidates
Medicare Law Puts Rx In Spotlight Of Presidential Campaign Politics
Restrictions on direct-to-consumer advertising of prescription drugs are among health care proposals being offered by 2004 Democratic presidential candidates
Senate Generic Reform Bill Likely To Result In Earlier ANDA Filings
A bipartisan Senate bill would encourage earlier ANDA filings by generics firms to head off new innovator patent listings and secure sole rights to 180-day exclusivity